KRMD
Price
$3.07
Change
+$0.05 (+1.66%)
Updated
Oct 20, 11:03 AM (EDT)
Capitalization
139.44M
22 days until earnings call
Intraday BUY SELL Signals
QDEL
Price
$13.11
Change
+$0.35 (+2.74%)
Updated
Oct 20, 11:18 AM (EDT)
Capitalization
875.02M
15 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KRMD vs QDEL

KRMD vs QDEL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
KRMD vs. QDEL commentary
Oct 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRMD is a StrongBuy and QDEL is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for KRMD with price predictions
Oct 19, 2026

KRMD sees its Stochastic Oscillator ascends from oversold territory

On October 14, 2026, the Stochastic Oscillator for KRMD moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 58 instances where the indicator left the oversold zone. In 50 of the 58 cases the stock moved higher in the following days. This puts the odds of a move higher at over 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where KRMD's RSI Oscillator exited the oversold zone, 14 of 18 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on KRMD as a result. In 92 of 109 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.

The Moving Average Convergence Divergence (MACD) for KRMD just turned positive on October 12, 2026. Looking at past instances where KRMD's MACD turned positive, the stock continued to rise in 36 of 48 cases over the following month. The odds of a continued upward trend are 75%.

Following a +4.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where KRMD advanced for three days, in 177 of 226 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

KRMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KRMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

The Aroon Indicator for KRMD entered a downward trend on October 08, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.725) is normal, around the industry mean (4.887). KRMD has a moderately low P/E Ratio (-75.500) as compared to the industry average of (35.995). Projected Growth (PEG Ratio) (1.770) is also within normal values, averaging (4.456). Dividend Yield (0.000) settles around the average of (0.006) among similar stocks. P/S Ratio (3.292) is also within normal values, averaging (56.074).

The Tickeron PE Growth Rating for this company is 19 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. KRMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 97 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KRMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for QDEL with price predictions
Oct 19, 2026

QDEL's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for QDEL turned positive on September 28, 2026. Looking at past instances where QDEL's MACD turned positive, the stock continued to rise in 35 of 49 cases over the following month. The odds of a continued upward trend are 71%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on QDEL as a result. In 53 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.

The 10-day moving average for QDEL crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.

Following a +9.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where QDEL advanced for three days, in 177 of 262 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

Bearish Trend Analysis

The 10-day RSI Indicator for QDEL moved out of overbought territory on October 14, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 19 similar instances where the indicator moved out of overbought territory. In 16 of the 19 cases, the stock moved lower in the following days. This puts the odds of a move lower at 84%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 52 of 63 cases where QDEL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 83%.

QDEL moved below its 50-day moving average on October 19, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where QDEL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

QDEL broke above its upper Bollinger Band on October 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for QDEL entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.493) is normal, around the industry mean (2.908). P/E Ratio (-0.827) is within average values for comparable stocks, (2.616). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.274) is also within normal values, averaging (40.124).

The Tickeron Seasonality Score of 44 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating fairly steady price growth. QDEL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QDEL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
KRMD vs QDEL: Fundamental Ratings
KRMD
QDEL
OUTLOOK RATING
1..100
9026
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
37
Fair valued
PROFIT vs RISK RATING
1..100
97100
SMR RATING
1..100
9498
PRICE GROWTH RATING
1..100
5057
P/E GROWTH RATING
1..100
1920
SEASONALITY SCORE
1..100
9044

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KRMD's Valuation (12) in the null industry is in the same range as QDEL (37) in the Medical Specialties industry. This means that KRMD’s stock grew similarly to QDEL’s over the last 12 months.

KRMD's Profit vs Risk Rating (97) in the null industry is in the same range as QDEL (100) in the Medical Specialties industry. This means that KRMD’s stock grew similarly to QDEL’s over the last 12 months.

KRMD's SMR Rating (94) in the null industry is in the same range as QDEL (98) in the Medical Specialties industry. This means that KRMD’s stock grew similarly to QDEL’s over the last 12 months.

KRMD's Price Growth Rating (50) in the null industry is in the same range as QDEL (57) in the Medical Specialties industry. This means that KRMD’s stock grew similarly to QDEL’s over the last 12 months.

KRMD's P/E Growth Rating (19) in the null industry is in the same range as QDEL (20) in the Medical Specialties industry. This means that KRMD’s stock grew similarly to QDEL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KRMDQDEL
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
62%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 12 days ago
68%
Declines
ODDS (%)
Bearish Trend 5 days ago
81%
Bearish Trend 2 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
81%
COMPARISON
Comparison
Oct 20, 2026
Stock price -- (KRMD: $3.02 vs. QDEL: $12.76)
Brand notoriety: KRMD and QDEL are both not notable
KRMD represents the Pharmaceuticals: Other, while QDEL is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: KRMD: 68% vs. QDEL: 91%
Market capitalization -- KRMD: $139.44M vs. QDEL: $875.02M
KRMD [@Pharmaceuticals: Other] is valued at $139.44M. QDEL’s [@Medical/Nursing Services] market capitalization is $875.02M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $153.03B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $180.06B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.1B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRMD’s FA Score shows that 2 FA rating(s) are green while QDEL’s FA Score has 1 green FA rating(s).

  • KRMD’s FA Score: 2 green, 3 red.
  • QDEL’s FA Score: 1 green, 4 red.
According to our system of comparison, KRMD is a better buy in the long-term than QDEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRMD’s TA Score shows that 6 TA indicator(s) are bullish while QDEL’s TA Score has 4 bullish TA indicator(s).

  • KRMD’s TA Score: 6 bullish, 2 bearish.
  • QDEL’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, KRMD is a better buy in the short-term than QDEL.

Price Growth

KRMD (@Pharmaceuticals: Other) experienced а +1.68% price change this week, while QDEL (@Medical/Nursing Services) price change was -3.70% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.50%. For the same industry, the average monthly price growth was -2.91%, and the average quarterly price growth was +7.01%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -3.67%. For the same industry, the average monthly price growth was -9.96%, and the average quarterly price growth was -11.00%.

Reported Earning Dates

KRMD is expected to report earnings on Nov 11, 2026.

QDEL is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+0.50% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-3.67% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
KRMD
Daily Signal:
Gain/Loss:
QDEL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BATRA54.600.60
+1.11%
Atlanta Braves Holdings
LVS38.01N/A
N/A
Las Vegas Sands Corp
FEIM65.12-0.06
-0.09%
Frequency Electronics
FINW10.50-0.18
-1.69%
FinWise Bancorp
ASTC4.74-0.18
-3.75%
Astrotech Corp

KRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRMD has been loosely correlated with QDEL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if KRMD jumps, then QDEL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRMD
1D Price
Change %
KRMD100%
+0.67%
QDEL - KRMD
40%
Loosely correlated
-1.16%
A - KRMD
40%
Loosely correlated
-1.77%
CLPT - KRMD
39%
Loosely correlated
+1.10%
BIO - KRMD
38%
Loosely correlated
-0.25%
NVST - KRMD
35%
Loosely correlated
-1.27%
More

QDEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, QDEL has been loosely correlated with AZTA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if QDEL jumps, then AZTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QDEL
1D Price
Change %
QDEL100%
-1.16%
AZTA - QDEL
51%
Loosely correlated
+2.20%
XRAY - QDEL
50%
Loosely correlated
-1.75%
RVTY - QDEL
50%
Loosely correlated
-1.11%
DHR - QDEL
49%
Loosely correlated
-2.01%
A - QDEL
48%
Loosely correlated
-1.77%
More